Check out your Company Bowl for anonymous work chats.
The U.S. Food and Drug Administration approved a new drug to treat adult patients with relapsing forms of multiple sclerosis (MS) and primary progressive multiple sclerosis (PPMS). Credits : Dr. Tapashi Mandal To know more about the disease and its treatment visit http://glassdoor.com/slink.htm?key=vQ4pp http://glassdoor.com/slink.htm?key=vQ4p1
Alphabet’s life sciences division, Verily, has launched its public pitch for a massive, multi-year health study it’s leading along with Duke University School of Medicine, Stanford Medicine and Google proper. http://glassdoor.com/slink.htm?key=vQ4p8
Would you swallow a sponge to detect #Cancer? http://glassdoor.com/slink.htm?key=vQ4pK Know more about cancer and its treatment on http://glassdoor.com/slink.htm?key=vQ4pT
"CRISPR Pill May Be Key in Fight Against Antibiotic Resistance" http://glassdoor.com/slink.htm?key=vQ4p6. Interested to know more about CRISPR and research related to it? Visit http://glassdoor.com/slink.htm?key=vQ4pW
U.S. Food and Drug Administration gives green signal to to Roche's TECENTRIQ as first-line treatment in bladder #cancer. http://glassdoor.com/slink.htm?key=vQ4pf
2017 seems to be the year when newer options in immunotherapy based #Cancer treatment would be available in the form of CAR-T based therapies. Visit http://glassdoor.com/slink.htm?key=vQ4pV to know more. http://glassdoor.com/slink.htm?key=vQ4pz
This is the best time to be in Biological Sciences because of the numerous studies being conducted and the innovations that come with those studies" says Daria Hazuda, Merck’s vice president of infectious disease discovery. To know more about Biological Sciences visit http://glassdoor.com/slink.htm?key=vQ4pj http://glassdoor.com/slink.htm?key=vQ4pw
This is the best time to be in Biological Sciences because of the numerous studies being conducted and the innovations that come with those studies" says Daria Hazuda, Merck’s vice president of infectious disease discovery. To know more about Biological Sciences visit iplexus.co http://glassdoor.com/slink.htm?key=vQ4pN
#WorldLiverDay is observed on every 19 April, to spread awareness about #liver related disease. We at Innoplexus help researchers in Life Sciences fast track their research through our discovery platform iPlexus - The Intelligence Machine. Register at http://glassdoor.com/slink.htm?key=vQ4p7 to access all publications, clinical trials, congresses and more for diseases related to Liver and all other therapeutic areas.
"A new personalized cancer vaccine has been designed to target 20 mutated proteins unique to each patient's tumors. The vaccine seems to have prevented early relapse in 12 patients with skin cancer, keeping them cancer free for more than 2 years." We are enabling researchers in #LifeSciences through our discovery platform 'iPlexus - The Intelligence Machine' that has entire LifeSciences data including Publications, Clinical Trials, Congresses, Theses & Dissertations and much more. Visit http://glassdoor.com/slink.htm?key=vQ4pU to get access. http://glassdoor.com/slink.htm?key=vQ4ps
